ctrl K

Price Alert

Myriad Genetics Inc. (MYGN)

NASDAQ: MYGN · Real-Time Price · USD

5.71

-0.18 (-3.06%)

At close: Aug 15, 2025, 3:59 PM

5.75

0.61%

After-hours: Aug 15, 2025, 07:15 PM EDT

Myriad Genetics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	102.4M	132.1M	56.9M	258.4M
Short-Term Investments	n/a	8.8M	58M	81.4M
Long-Term Investments	n/a	n/a	54.8M	59M
Other Long-Term Assets	8.5M	15.4M	15.5M	8.3M
Receivables	121.2M	114.3M	101.6M	91.3M
Inventory	27.5M	22M	20.1M	15.3M
Other Current Assets	30.5M	19.4M	20.4M	38.4M
Total Current Assets	298M	313.6M	274.6M	484.8M
Property-Plant & Equipment	172.4M	180.6M	187.3M	125.3M
Goodwill & Intangibles	548.7M	636.9M	666.5M	643.3M
Total Long-Term Assets	729.6M	832.9M	924.1M	835.9M
Total Assets	1.03B	1.15B	1.2B	1.32B
Account Payables	32.3M	25.8M	28.8M	29.6M
Deferred Revenue	n/a	n/a	600K	5.2M
Short-Term Debt	n/a	n/a	14.1M	13M
Other Current Liabilities	64.9M	38.2M	93.7M	156.5M
Total Current Liabilities	164.1M	155.9M	137.2M	204.3M
Long-Term Debt	39.6M	38.5M	130.9M	79.3M
Other Long-Term Liabilities	34.9M	71.5M	41.3M	33.5M
Total Long-Term Liabilities	162.4M	207.4M	175.7M	148.6M
Total Liabilities	326.5M	363.3M	312.9M	352.9M
Total Debt	140.3M	152.1M	145M	92.3M
Common Stock	900K	900K	800K	800K
Retained Earnings	-756.8M	-629.5M	-366.2M	-254.2M
Comprehensive Income	-800K	-3.7M	-8.9M	-5.1M
Shareholders Equity	701.1M	783.2M	885.8M	967.8M
Total Investments	n/a	8.8M	112.8M	140.4M